Clinical Trial Update: Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GSK189254 for narcolepsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• GSK189254

Snippet

Sponsor: GlaxoSmithKline | Conditions: Narcolepsy | Phase 2 | Status: TERMINATED